Biotech Breakthroughs

Results

56

2 new

Biotech stocks worldwide which are expected to become profitable in the next 3 years.

56 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
	MDGL	US$516.74	1.8%	24.6%	US$11.9b	US$678.06	9.3	63.7%	n/a	Pharmaceuticals & Biotech
	INSM	US$125.77	1.6%	-4.6%	US$27.5b	US$200.05	24.1	67.0%	n/a	Pharmaceuticals & Biotech
	PRAX	US$375.94	2.5%	670.7%	US$10.5b	US$638.68	7.8	71.7%	n/a	Pharmaceuticals & Biotech
	ANAB	US$57.74	-1.2%	185.6%	US$1.7b	US$87.09	7.4	48.1%	39.0%	Pharmaceuticals & Biotech
	MRKR	US$1.39	21.9%	7.8%	US$23.2m	US$7.87	8.6	72.5%	n/a	Pharmaceuticals & Biotech
	ARDX	US$3.89	-4.2%	-36.3%	US$969.3m	US$12.90	2.1	61.5%	n/a	Pharmaceuticals & Biotech
	ZYME	US$28.67	14.1%	89.9%	US$2.0b	US$40.33	54.8	39.6%	n/a	Pharmaceuticals & Biotech
	IONS	US$59.74	4.4%	39.9%	US$9.9b	US$88.00	11.4	68.7%	n/a	Pharmaceuticals & Biotech
	ALDX	US$1.52	-2.6%	-73.8%	US$91.7m	US$6.60	2.4	55.2%	n/a	Pharmaceuticals & Biotech
	CLRB	US$2.59	-0.4%	-46.9%	US$24.5m	US$11.50	0.8	56.0%	n/a	Pharmaceuticals & Biotech
	CAPR	US$6.29	-5.4%	-11.4%	US$365.7m	US$10.50	1.5	62.7%	n/a	Pharmaceuticals & Biotech
	INMB	US$2.32	6.9%	-3.7%	US$64.4m	US$7.00	3.2	43.4%	n/a	Pharmaceuticals & Biotech
	TNYA	US$0.70	-4.2%	-38.3%	US$156.4m	US$3.20	117.1	67.8%	n/a	Pharmaceuticals & Biotech
	RVMD	US$209.46	2.8%	466.0%	US$44.9b	US$223.24	17.2	60.0%	n/a	Pharmaceuticals & Biotech
	RNXT	US$1.32	-5.7%	40.4%	US$59.6m	US$7.00	30.1	77.2%	n/a	Pharmaceuticals & Biotech
	LCTX	US$1.08	0.9%	-10.0%	US$273.1m	US$5.50	20.9	74.5%	n/a	Pharmaceuticals & Biotech
	ABEO	US$6.09	1.8%	-15.8%	US$348.3m	US$18.86	13.6	70.2%	n/a	Pharmaceuticals & Biotech
	CGON	US$79.81	6.4%	196.5%	US$7.1b	US$91.08	1135.9	62.0%	n/a	Pharmaceuticals & Biotech
	ACIU	US$2.90	16.5%	34.9%	US$288.3m	US$8.61	13.2	45.3%	n/a	Pharmaceuticals & Biotech
	VRDN	US$24.29	10.0%	26.3%	US$2.8b	US$36.63	38.7	63.0%	n/a	Pharmaceuticals & Biotech
	LGVN	US$0.84	14.2%	5.6%	US$26.9m	US$7.15	22.7	60.1%	n/a	Pharmaceuticals & Biotech
	NAMS	US$27.87	3.3%	11.5%	US$3.3b	US$51.44	467.8	65.3%	n/a	Pharmaceuticals & Biotech
	MNOV	US$1.39	6.1%	5.9%	US$68.4m	US$9.00	74.3	71.2%	n/a	Pharmaceuticals & Biotech
	VERA	US$32.28	2.0%	43.0%	US$2.3b	US$77.14	5.7	65.8%	n/a	Pharmaceuticals & Biotech

Page 1 of 2